on June 30, 2003
Published online before print June 30, 2003, doi: 10.1161/01.CIR.0000080326.15367.0C
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on February 18, 2003
From the Department of Neurosurgery (D.B.E., J.E.C., M.E.S.) and the Cardiovascular Division (H.L.P., A.L.K., S.K., J.S., J.R.L.), University of Virginia School of Medicine, Charlottesville. * To whom correspondence should be addressed. E-mail: jlindner{at}virginia.edu.
Background--Angiogenesis is a critical determinant of tumor growth and metastasis. We hypothesized that contrast-enhanced ultrasound (CEU) with microbubbles targeted to Methods and Results--Malignant gliomas were produced in 14 athymic rats by intracerebral implantation of U87MG human glioma cells. On day 14 or day 28 after implantation, CEU was performed with microbubbles targeted to Conclusions--CEU with microbubbles targeted to
Revised on April 9, 2003
Accepted on April 9, 2003
Imaging Tumor Angiogenesis With Contrast Ultrasound and Microbubbles Targeted to
Dilantha B. Ellegala MD, 
v
3
v-integrins expressed on the neovascular endothelium could be used to image angiogenesis.v
3 by surface conjugation of echistatin. CEU perfusion imaging with nontargeted microbubbles was used to derive tumor microvascular blood volume and blood velocity. Vascular v-integrin expression was assessed by immunohistochemistry, and microbubble adhesion was characterized by confocal microscopy. Mean tumor size increased markedly from 14 to 28 days (2±1 versus 35±14 mm2, P<0.001). Tumor blood volume increased by 
35% from day 14 to day 28, whereas microvascular blood velocity decreased, especially at the central portions of the tumors. On confocal microscopy, v3-targeted but not control microbubbles were retained preferentially within the tumor microcirculation. CEU signal from v3-targeted microbubbles in tumors increased significantly from 14 to 28 days (1.7±0.4 versus 3.3±1.0 relative units, P<0.05). CEU signal from v3-targeted microbubbles was greatest at the periphery of tumors, where v-integrin expression was most prominent, and correlated well with tumor microvascular blood volume (r=0.86).v3 can noninvasively detect early tumor angiogenesis. This technique, when coupled with changes in blood volume and velocity, may provide insights into the biology of tumor angiogenesis and be used for diagnostic applications.
Key words: angiogenesis • cancer • ultrasound
This article has been cited by other articles:
 |
|
 |
|
  S. Kaul Myocardial Contrast Echocardiography: A 25-Year Retrospective Circulation, July 15, 2008; 118(3): 291 - 308. [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Lee, A. Lyshchik, J. Huamani, D. E. Hallahan, and A. C. Fleischer Relationship Between Retention of a Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)-Targeted Ultrasonographic Contrast Agent and the Level of VEGFR2 Expression in an In Vivo Breast Cancer Model J. Ultrasound Med., June 1, 2008; 27(6): 855 - 866. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Cai and X. Chen Multimodality Molecular Imaging of Tumor Angiogenesis J. Nucl. Med., June 1, 2008; 49(Suppl_2): 113S - 128S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Vicenzini, R. Delfini, F. Magri, F. Puccinelli, M. Altieri, A. Santoro, M. F. Giannoni, L. Bozzao, V. Di Piero, and G. L. Lenzi Semiquantitative Human Cerebral Perfusion Assessment With Ultrasound in Brain Space-Occupying Lesions: Preliminary Data J. Ultrasound Med., May 1, 2008; 27(5): 685 - 692. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. Kruskal Can Contrast-enhanced US with Targeted Microbubbles Monitor the Response to Antiangiogenic Therapies? Radiology, February 1, 2008; 246(2): 339 - 340. [Full Text] [PDF]
|
|
|
|
|
|
J. K. Willmann, R. Paulmurugan, K. Chen, O. Gheysens, M. Rodriguez-Porcel, A. M. Lutz, I. Y. Chen, X. Chen, and S. S. Gambhir US Imaging of Tumor Angiogenesis with Microbubbles Targeted to Vascular Endothelial Growth Factor Receptor Type 2 in Mice Radiology, February 1, 2008; 246(2): 508 - 518. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Palmowski, J. Huppert, G. Ladewig, P. Hauff, M. Reinhardt, M. M. Mueller, E. C. Woenne, J. W. Jenne, M. Maurer, G. W. Kauffmann, et al. Molecular profiling of angiogenesis with targeted ultrasound imaging: early assessment of antiangiogenic therapy effects Mol. Cancer Ther., January 1, 2008; 7(1): 101 - 109. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Lyshchik, A. C. Fleischer, J. Huamani, D. E. Hallahan, M. Brissova, and J. C. Gore Molecular Imaging of Vascular Endothelial Growth Factor Receptor 2 Expression Using Targeted Contrast-Enhanced High-Frequency Ultrasonography J. Ultrasound Med., November 1, 2007; 26(11): 1575 - 1586. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Hricak, P. L. Choyke, S. C. Eberhardt, S. A. Leibel, and P. T. Scardino Imaging Prostate Cancer: A Multidisciplinary Perspective Radiology, April 1, 2007; 243(1): 28 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Cai, J. Rao, S. S. Gambhir, and X. Chen How molecular imaging is speeding up antiangiogenic drug development. Mol. Cancer Ther., November 1, 2006; 5(11): 2624 - 2633. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Cai, Y. Wu, K. Chen, Q. Cao, D. A. Tice, and X. Chen In vitro and In vivo Characterization of 64Cu-Labeled AbegrinTM, a Humanized Monoclonal Antibody against Integrin {alpha}v{beta}3 Cancer Res., October 1, 2006; 66(19): 9673 - 9681. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Vicenzini, M. C. Ricciardi, F. Puccinelli, and G. L. Lenzi Cerebral Perfusion in a High-Grade Glioma Evaluated With Sonographic Contrast Pulse Sequencing Technology. J. Ultrasound Med., September 1, 2006; 25(9): 1215 - 1218. [Full Text] [PDF]
|
|
|
|
 |
|
 F. A. Jaffer, P. Libby, and R. Weissleder Molecular and Cellular Imaging of Atherosclerosis: Emerging Applications J. Am. Coll. Cardiol., April 4, 2006; 47(7): 1328 - 1338. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Provenzale Good Things Come in Small Packages: A Review of the Proceedings of the 2005 Academy of Molecular Imaging Meeting Am. J. Roentgenol., February 1, 2006; 186(2): 291 - 296. [Full Text] [PDF]
|
|
|
|
|
|
X. Zhang, Z. Xiong, Y. Wu, W. Cai, J. R. Tseng, S. S. Gambhir, and X. Chen Quantitative PET Imaging of Tumor Integrin {alpha}v{beta}3 Expression with 18F-FRGD2 J. Nucl. Med., January 1, 2006; 47(1): 113 - 121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Wu, X. Zhang, Z. Xiong, Z. Cheng, D. R. Fisher, S. Liu, S. S. Gambhir, and X. Chen microPET Imaging of Glioma Integrin {alpha}v{beta}3 Expression Using 64Cu-Labeled Tetrameric RGD Peptide J. Nucl. Med., October 1, 2005; 46(10): 1707 - 1718. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Leong-Poi, J. Christiansen, P. Heppner, C. W. Lewis, A. L. Klibanov, S. Kaul, and J. R. Lindner Assessment of Endogenous and Therapeutic Arteriogenesis by Contrast Ultrasound Molecular Imaging of Integrin Expression Circulation, June 21, 2005; 111(24): 3248 - 3254. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Achilefu, S. Bloch, M. A. Markiewicz, T. Zhong, Y. Ye, R. B. Dorshow, B. Chance, and K. Liang Synergistic effects of light-emitting probes and peptides for targeting and monitoring integrin expression PNAS, May 31, 2005; 102(22): 7976 - 7981. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Abramowicz Ultrasonographic Contrast Media: Has the Time Come in Obstetrics and Gynecology? J. Ultrasound Med., April 1, 2005; 24(4): 517 - 531. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-H. Lee, K.-H. Jung, S.-H. Song, D. H. Kim, B. C. Lee, H. J. Sung, Y.-M. Han, Y. S. Choe, D. Y. Chi, and B.-T. Kim Radiolabeled RGD Uptake and {alpha}v Integrin Expression Is Enhanced in Ischemic Murine Hindlimbs J. Nucl. Med., March 1, 2005; 46(3): 472 - 478. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Miller, H. H. Pien, D. Sahani, A. G. Sorensen, and J. H. Thrall Imaging Angiogenesis: Applications and Potential for Drug Development J Natl Cancer Inst, February 2, 2005; 97(3): 172 - 187. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P.A Dijkmans, L.J.M Juffermans, R.J.P Musters, A van Wamel, F.J ten Cate, W van Gilst, C.A Visser, N de Jong, and O Kamp Microbubbles and ultrasound: from diagnosis to therapy Eur J Echocardiogr, August 1, 2004; 5(4): 245 - 246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Lindner and J. Sklenar Placing faith in numbers: quantification of perfusion with myocardial contrast echocardiography J. Am. Coll. Cardiol., May 19, 2004; 43(10): 1814 - 1816. [Full Text] [PDF]
|
|
|
|
|
|
J. N. Kirkpatrick, T. Wong, J. E. Bednarz, K. T. Spencer, L. Sugeng, R. P. Ward, J. M. DeCara, L. Weinert, T. Krausz, and R. M. Lang Differential diagnosis of cardiac masses using contrast echocardiographic perfusion imaging J. Am. Coll. Cardiol., April 21, 2004; 43(8): 1412 - 1419. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Foster and I. L. Gerber Masses of the heart: perfusing the "good" from the bad J. Am. Coll. Cardiol., April 21, 2004; 43(8): 1420 - 1422. [Full Text] [PDF]
|
|
|
|
 |
|
 F. A. Jaffer and R. Weissleder Seeing Within: Molecular Imaging of the Cardiovascular System Circ. Res., March 5, 2004; 94(4): 433 - 445. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kaul and J. R. Lindner Visualizing coronary atherosclerosis in vivo: thinking big, imaging small J. Am. Coll. Cardiol., February 4, 2004; 43(3): 461 - 463. [Full Text] [PDF]
|
|
|
|
 |
|
 H-D Liang and M J K Blomley The role of ultrasound in molecular imaging Br. J. Radiol., December 1, 2003; 76(suppl_2): S140 - S150. [Abstract] [Full Text] [PDF]
|
|